Research Article Open Access

Cubic Nanoparticles as Potential Carriers for A Natural Anticancer Drug: Development, In Vitro and In Vivo Characterization

Abstract

Natural compounds that elicit anticancer properties are of great interest for cancer therapy. However, the low solubility and bioavailability of these compounds limit their use as efficient anticancer drugs. To avoid these drawbacks, incorporation of these compounds into cubic nanoparticles (cubosomes) was carried out. Cubosomes containing bergapten which is a natural anticancer compound isolated from Ficus carica were prepared by the homogenization technique using monoolein and poloxamer. These cubosomes were characterized for size, zeta potential, entrapment efficiency, small angle X-ray diffraction, In-vitro release, In-vitro cytotoxicity, cellular uptake, and antitumor activity. Particle size of cubosomes was 220 ± 3.6 nm with almost neutral zeta potential -5 ± 1.2 mV and X-ray measurements confirmed the existence of the cubic structure. Additionally, more than 90% of the natural anticancer drug was entrapped within the cubosomes. A sustained release over 30 hours was obtained for these cubosomes. Finally, these cubosomes illustrated higher In-vitro cytotoxicity and In-vivo tumor inhibition compared with the free natural anticancer compound. Thus, cubosomes could be promising carriers for enhancement of antitumor efficiency of this natural compound.

Randa Abdou1, Mariam Mojally2, Gouda H Attia3, Mohamed Dawoud4,5

To read the full article Download Full Article | Visit Full Article